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Abstract
Objectives To evaluate the radiation dose in routine
multidetector computed tomography (MDCT) examinations
in Italian population.
Methods This was a retrospective multicentre study included
5,668 patients from 65 radiology departments who had
undergone common CT protocols: head, chest, abdomen,
chest–abdomen–pelvis (CAP), spine and cardiac. Data includ-
ed patient characteristics, CT parameters, volumetric CT dose
index (CTDIvol) and dose length product (DLP) for each CT
acquisition phase. Descriptive statistics were calculated, and a
multi-regression analysis was used to outline the main factors
affecting exposure.
Results The 75th percentiles of CTDIvol (mGy) and DLP
(mGy cm) for whole head were 69 mGy and 1,312 mGy cm,
respectively; for chest, 15 mGy and 569 mGy cm; spine,
42 mGy and 888 mGy cm; cardiac, 7 mGy and 131 mGy cm
for calcium score, and 61 mGy and 1,208 mGy cm for angio-
graphic CT studies. High variability was present in the DLP of
abdomen and CAP protocols, where multiphase examinations
dominated (71% and 73% respectively): for abdomen, 18mGy,
with 555 and 920 mGy cm in abdomen and abdomen–pelvis
acquisitions respectively; for CAP, 17 mGy, with 508, 850
and 1,200 mGy cm in abdomen, abdomen–pelvis and CAP
acquisitions respectively.
Conclusion The results of this survey could help in the
definition of updated diagnostic reference levels (DRL).
Key Points
• Radiation dose associated with multidetector CT (MDCT) is
an important health issue.
• This national survey assessed dose exposures of 5,668
patients undergoing MDCT.
• Dose indices correlate with BMI, voltage, rotation time,
pitch and tube current.
• These results may contribute to an update of national diag-
nostic reference levels.
Keywords Nationwide survey . Radiation protection .
Multidetector CT . Patient dose . Diagnostic reference levels
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Introduction
Computed tomography (CT) has dramatically changed since
the publication of the first European guidelines for computed
tomography in 1999 [1], wherein diagnostic reference levels
(DRL) were proposed, and its update in 2004 [2].
The most fundamental change to CT is the increased num-
ber of detector rows, but evolution has also been seen in
hardware improvements (x-ray tube, detectors, etc.) and soft-
ware developments (dose reduction systems, new reconstruc-
tion algorithms) that allow faster acquisition and higher image
quality to be achieved [3–9].
A practical consequence of this rapid evolution is that CT
examinations are no longer limited to a single anatomical
region and a maximum of two CT data acquisitions (without
and with contrast media). Instead, whole-body and multiphase
examinations are increasingly common.
The resulting relevant increase in dose to the patient is an
issue of international concern that has emerged in the scien-
tific literature over the last 10 years [10, 11] despite a number
of advances in dose reduction systems, indicating that further
optimisation is still required [5–9]. Equally, awareness and
guidance on the risk associated with these increased dosages
are needed, but the present Italian DRLs established by Italian
law (D.Lgs. 187/2000) [12] refer to the old European guidelines
of 1999.
The volumetric CT dose index (CTDIvol) and the dose
length product (DLP) are still the two main CT dose descrip-
tors, and can be collected from the dose report, which is a page
summary sheet produced by the CT system at the end of each
CT examination. As the CTDIvol and DLP are calculated with
reference to phantom measurements, they provide only a
rough estimation of the dose to the patient, but are nonetheless
a useful tool for protocol optimisation and dose reduction [2].
This article provides a comprehensive overview of the state
of practice of multidetector CT (MDCT) examinations in Italy
for common clinical disorders. It is part of a major project that
started in 2010 and was sponsored by the Italian Society of
Radiology (SIRM) in collaboration with the Italian Society of
Medical Physics (AIFM). In this retrospective multicentre
study, we collected acquisition and dosimetric parameters from
a large number of patients who underwent CTexaminations for
common clinical indications. The study was approved and
registered by ClinicalTrials.gov (Identifier: NCT01436006).
Previous Italian studies refer to single-slice CT [13] or to
DRL collection in single Italian regions (Val d’Aosta [14] and
Emilia Romagna [15]). Similar analyses have previously been
conducted in the UK [16] and Germany [17], but were
concerned mainly with single- or four-slice CT. Other studies
in patients of paediatric age have been performed in Switzerland
[18], Germany [19] and France [20]. More recent experience
with MDCT has been examined in Ireland [21] and Malta [22],
both in a small group of hospitals. Less detailed reports, based
on the collection of local DRLs, are also available, but they do
not give a full description of everyday practice [23–26].
This survey aimed to provide extensive and up-to-date
information on the practice of MDCT in Italy that can serve
as a benchmark for future European analyses and for improv-
ing CT imaging and dose optimisation.
We evaluated the magnitude of radiation dose to patients,
in terms of CTDIvol and DLP, and the CT acquisition settings
including the use of dose reduction systems. Particular atten-
tion was paid to multiphase examinations: we collected both
the DLP, referring to a single acquisition (DLP), and the DLP
of a complete patient examination (total DLP). The associa-
tion of radiation dose with the different acquisitions and
patient characteristics was also investigated.
Materials and methods
Data collection
This retrospective multicentre study was organised in two
phases. The first was intended to select a significant sample
including those centres that perform a relevant number of
adult examinations per year and carry out a regular pro-
gramme of quality checks in their CT units. The second was
devoted to collecting details of the CT examinations carried
out in those centres (including CT protocol and dosimetric
parameters) for each patient. In both phases, the participating
centres (see Appendix) filled in pre-established forms and
uploaded them to an on-line database.
Phase 1
All radiologist members of SIRM (of public, private or aca-
demic hospitals) and regularly performing MDCT studies in
adults were invited to participate to this open-call study. This
study was approved by the ethics committee of the two
leading centres (European Institute of Oncology of Milan,
and University Hospital Palermo).
In the preliminary questionnaire the centres were asked to
indicate the number of CT examinations performed in 2009
for six different CT protocols: head, abdomen, chest, spine,
heart and chest–abdomen–pelvis (CAP).
In addition, they were asked to report the main features of
their MDCT apparatus: the CT system manufacturer, model,
year of installation and the number of detector rows. Finally,
they were asked tomeasure the CTDIvol following the European
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guidelines EUR16262/1998 [1] and to verify that the measured
value was within ±10 % of the console displayed CTDIvol.
Phase 2
All centres performing at least 10,000 CT examinations per
year using CT systems capable of acquiring at least 16 slices
simultaneously and with a responsible medical physicist were
invited to participate. The clinical indications for the protocols
of interest were trauma, ischaemic stroke, haemorrhage for
head; cancer diagnosis and staging, infection for chest; cancer
diagnosis and staging, vascular disorder, abscess and trauma
for abdomen; cancer for CAP; general indications for spine;
coronary disease of native vessels for cardiac acquisitions
(Table 1). The requested clinical indications are the most
frequent according to the 2009 Italian report [27], the previous
experience conducted by Shrimpton et al. [16] and the US
IMV benchmark report [28], except for cardiac CT study,
which is an emerging CT indication.
In preparation for the second phase, the centres were
grouped according to their geographical location according to
the four macro-areas of the nation: North East, North West,
Centre, and South and Islands. Each centre was then asked to
provide data from individual CTexaminations proportionally to
the total volume of CT studies performed in 1 year for each
protocol and to the total number of examinations performed in
the corresponding macro-area [27]. The sample size for the
individual CT examinations was planned to guarantee a confi-
dence level of 95% and an absolute error of 5% on the average
dose, with simple random sampling and assuming that the
standard deviation of dose values per CT acquisition series
was twice the one estimated in a similar German nationwide
survey of exposure practice for 11- to 15-year-old children [19].
The reporting centres completed pre-established forms de-
veloped following the UK survey 2003 [16], with adaptation
for MDCT examinations. The data sheet included the clinical
indication and the main data of the patients enrolled in the
survey: the age, the gender, the pseudonymous ID number (in
order to easily retrieve the examination reports in case we
needed to verify reported data) and, if available, the weight
and height. Since a patient’s CT investigation may involve
several CT acquisition phases, the centres recorded the tech-
nical and dosimetric data for each of them as described in the
Appendix.
Data validation
The data set was verified for completeness and consistency
with broad and cross checks of the records in the database.
First of all, missing values and outliers from the individual
parameter distributions were sought in order to identify pos-
sible mistakes. As data were manually registered in the data
sheet, the outliers were mainly caused by mistakes in unit
conversion or transcription errors, for example in comma
positioning or inversion of fields. Those were immediately
corrected. Further, possible inconsistencies in the data were
tested for by making use of redundancies in the information
collected (e.g. the CTDIvol multiplied by the anatomical length
of the CT acquisition should be lower than the DLP). Errors
outlined in this way were compared with CT examinations
provided by the same centre in order to point out unusual
acquisitions.
All data sheets identified by this process were then
analysed in detail. If necessary, the participating centres were
requested, by mail, phone or both, to perform integration of
the incomplete data or correction of inconsistent data.
Table 1 CT studies included in
the survey, with the number of CT
scanners, the clinical indications
considered, the number of
patients examined and the
number of CT acquisitions
performed
CAP chest–abdomen–pelvis,
HCC hepatocellular carcinoma
a Total is not sum as in most
centres scanners were used
for more than one protocol
CT protocol n of CT
scanners
Clinical indication n of patients n of CT
acquisitions
Head 59 Ischaemic stroke and/or haemorrhage 764 1,027
Trauma (no circle of Willis) 345 386
Chest 67 Vascular/infection 587 805
Cancer diagnosis and staging
(no screening low dose)
681 922
Abdomen 64 Abscess 225 475
General vascular event 150 370
Cancer diagnosis and staging
(no HCC study, no CT urography)
686 1,851
Trauma 161 284
CAP 65 Cancer staging 1,237 2,905
Cardiac 11 Coronary disease of native vessels 287 457
Spine 38 General indication 545 731
Total 70a 5,668 10,213
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At the end of this process, forms with more than one
missing value or inconsistencies, not ascribable to transcrip-
tion errors or mistakes in unit conversions, were excluded
from analysis.
As it was known that some older CTsystems provided dose
reports containing the maximum instead of the mean CTDIvol
values for acquisitions with automatic dose modulation, the
mean CTDIvol in such cases was estimated from the DLP
divided by the CT acquisition length.
Data validation and analysis were conducted using pro-
grams written in the R language (software version R 2.10.1
GUI 1.31 Leopard build 64-bit (5537)).
Statistical analysis
For continuous, normally distributed variables, such as patient
weight and height, results were expressed as mean values
(MV) ± standard deviation (SD) The non-normally distributed
variables, such as CTDIvol, DLP, voltage (kV), tube rotation
time (s), reconstructed slice thickness (mm), z-coverage
length (mm), CT acquisition field of view (FOV) (mm), pitch
and tube current (mA), and average mAs, were described with
the median value and the interquartile range (the 25th–75th
percentiles), unless otherwise stated. Categorical variables,
such as tube current modulation (with/without), CT technique
(spiral/axial), contrast media (with/without), and, for cardiac
studies, acquisition method (prospective/retrospective), beta-
blockers administration (with/without) and electrocardio-
graphically controlled tube current modulation (ECTCM)
(with/without), were expressed as percentages.
In-depth analysis was performed in order to investigate how
CTDIvol is associated with the different CT acquisition tech-
niques andwith the patient anatomical characteristics. Owing to
the non-normality of CTDIvol values, its logarithm was used to
approximate the normal distribution. At univariate analysis,
log(CTDIvol) distributions were compared with categorical var-
iables, using nested ANOVA or the non-parametric k-sample
equality of medians tests. The comparison of log(CTDIvol)
distributions with continuous variables was instead performed
either with parametric or non-parametric ANCOVA. All con-
tinuous variables were standardized.
Thereafter, a multivariate analysis was performed for
CTDIvol including only statistically significant explanatory
variables at univariate analysis (P <0.05). In order to take into
account the correlation structure existing for patients observed
within the same radiology unit, the CTDIvol was modelled
through a generalized estimating equations (GEE) model with
gamma distribution and log link [29, 30]. Final results are
given as exponential coefficients and corresponding confi-
dence intervals (CI). All analyses were performed using
StataMP version 11.0 (StataCorp LP, College Station, TX)
and statistical significance was assumed at a level of P <0.05.
Results
The sample
In response to the phase 1 survey and the following in-depth
reports, the study sample involved a total of 65 radiology
departments with 70 MDCT systems, and included data from
5,942 randomly chosen adult patients, who underwent CT
using one of the six CT protocols. In the data validation
process we corrected 5 % of completed fields, and excluded
274 data sheets. In this way the 95 % of the collected forms
were recovered, yielding a total of 5,668 patient CT examina-
tions and 10,213 CT acquisitions in the final study sample
(Table 1). The CT examinations were performed between
January and November 2011. The 70 MDCT systems in-
volved in the study represented 8 % of the 871 systems
estimated in Italy in 2009 [27]. In light of the number of
responses received we verified an actual confidence level of
70 % with 9 % as margin of error on dose parameters.
Figure 1 shows the percentages of MDCT systems and
patients included in the sample according to macro-area, CT
protocol, number of slices and manufacturers.
The sampling rate was broadly appropriate (85 % of re-
quested), although North West was over-represented and the
other geographic domains were somewhat under-represented,
especially for spine and cardiac protocols, because fewer
centres perform these studies.
The 16- and 64-slice MDCTs accounted for the majority of
the systems in the study (26 [37%] and 34 [49%] respectively).
Nearly all of the CT manufactures are represented, with GE
machines being the most prevalent (43 %) (Fig. 1).
The patients included in the sample were almost equally
divided between women and men: 2,647 (47 %) and 3,044
(53 %) respectively, with an average age of 64±16 for both
genders. The height and weight of the patients were retrospec-
tively recovered for a subset of sample only (23 % of all
patients for weight and 29 % for height). We found mean
weight and height to be 68±13 kg and 163±7 cm for women
and 77±12 kg and 173±8 cm for men, corresponding to
an average BMI (body mass index) of 26±8 kg/m2 for
both genders. This BMI value is slightly above that of
the standard man commonly considered for establishing
the DRLs. However, the study population had a mean
age of 64 years and, at this age, the average BMI being
higher is in agreement also with the data of the National
Institute of Statistics (ISTAT) [31].
CT parameters
Table 2 shows the CTsystem settings chosen in each protocol.
Since the introduction of MDCT, although most head
acquisitions are performed with CT acquisitions covering the
whole head, some examinations (157) are still performed in
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two shorter sequences (posterior fossa and the supratentorial
region). These examinations were therefore analysed separately.
For cardiac acquisitions, six of the 11 centres routinely
performed a calcium score test before the angiographic
phase, four of them performed only the angiographic CT
acquisition, and one centre used both methods. The calcium
scoring and angiographic CT acquisitions were separately
reported.
A tube voltage of 120 kV was the leading choice in all
protocols except for posterior fossa CT acquisitions, where
63.9 % of acquisitions were performed with higher voltages.
Note that a significant part of angiographic studies (40.6 %)
were performed at lower voltages, whereas for spine 43.9% of
CT acquisitions were performed at higher values.
Tube current modulation was widely applied in all proto-
cols, except those on the whole head (30.7 %) and in calcium
score acquisitions (29 %). For angiographic CTexaminations,
acquisitions with or without modulation were almost equally
distributed (53.6 % and 46.4 % respectively). The lowest
values of tube current settings were found for head in two
parts, chest, abdomen and CAP acquisitions where, for exam-
ple, we havemedian values equal or below 250mA in the case
of fixed tube current. For chest, abdomen and CAP protocols,
the tube rotation time was also quite low: median values of
0.5, 0.6 and 0.6 s respectively. Higher values were found for
head and spine CT (1 s as median value).
An exception was the angiographic acquisition in heart
studies, where a high tube current (median 650 mA), used to
maintain high image quality, was associated with a very low
tube rotation time (median 0.35 s), necessary to reduce move-
ment artefacts due to heart beating.
Helical CTwas almost always used in chest, abdomen and
CAP acquisitions (more than 99 % of cases), with a median
pitch of 0.98, 0.97 and 0.98, respectively. Spiral CT data
acquisitions were also commonly used in spine (65 %) and
cardiac angioCT studies (76.8 %), whereas axial imaging
dominated for calcium scoring and head acquisitions
(86.6 % and 52.6 % respectively). When the head was ac-
quired in two parts, however, the axial mode was the unique
choice (100 % of CT acquisitions).
The highest values of reconstructed slice thickness were
found for head (median value 4.5 mm). In this case, when it
was acquired in two parts, the supratentorial region was
reconstructed at 5 mm, and the posterior fossa at lower slice
thickness (2.5 mm). Lower slice thicknesses were used for
spine, chest, abdomen, CAP and calcium score acquisitions,
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with a range of 2.4–3.5 mm. The lowest thickness was
found in angiographic acquisitions, with 0.625 mm as
median value.
In Table 2 we also show the anatomical length of the
examination. As expected, the shorter head acquisitions sum
to the whole head length. We also remark that anatomical
lengths span a wide range for abdomen and CAP studies.
The distribution of z-axis coverage lengths (Fig. 2a) showed
the presence of two Gaussian peaks because in clinical prac-
tice an abdomen protocol can refer either to abdomen or
abdomen–pelvis acquisitions.
Contrast medium was more often used for abdomen, CAP
and cardiac studies. The CT acquisition FOV was larger
for chest, abdomen and CAP acquisitions. The values
obtained for collimation, reconstruction filter and image quality
index (not reported in Table 2) were not consistent or largely
unavailable.
Dosimetric values
Table 3 summarises the dosimetric values obtained in each
protocol, including all the relative clinical indications, with
sub-analyses on peculiar CT phases or anatomical regions.We
show the mean CTDIvol obtained in each CT acquisition, the
DLP per acquisition and the total DLP, which is relative to the
complete patient CT examination (that can comprise more
than one CT acquisition).
In Fig. 2b–d we show, as an example, the distribution of
CTDIvol and DLP indices for the abdomen protocol. They are
non-normally distributed and show a positive skew. This is a
general feature found in all protocols. However, data are
presented with their mean value (MV), standard deviation
(SD) and the 25th, 50th and 75th percentiles for easier com-
parison with previous studies. Despite the validation analysis,
data still show high variability.
As expected, there is a notable difference between
DLP and total DLP in those protocols where many phases
per patient CT examination are carried out (abdomen, CAP),
see Fig. 3.
Multiphase examinations
The very fast acquisition times, allowed by the high perfor-
mance ofMDCTsystems, has led to an increase of multiphase
studies and, likewise, to a wide variety of CT protocols—even
within the same centre—for the same anatomical region and
clinical indication.
In this study we found that multiphase examinations ac-
count for 71 % and 73 % of all CT examinations in abdomen
and CAP protocols respectively (Fig. 3). This is particularly
true for cancer and haemorrhage clinical indications in ab-
dominal studies, where the multiphase studies account for
81 % and 79 % respectively, and a relevant part of the CT
studies is performed with at least three CT acquisition phases
(59 % and 54 % respectively).
In head, chest and spine, the percentages of multiphase CT
examinations are lower: 18 %, 31 %, and 16 % respectively.
Figure 4 shows how the total DLP, which is the relevant
parameter used to estimate the risk relative to patient expo-
sures, increases with the number of phases.
As we noted above (Table 2, Fig. 2a), the different acquisi-
tions in abdomen and CAP protocols covered a wide range of
anatomical lengths. This is because a single abdominal study
(e.g. cancer diagnosis) can comprise four phases, with some of
Fig. 2 Distribution of a z-axis
coverage, b CTDIvol, c DLP and
d total DLP for the abdomen
protocol. Best-fit Gaussian curves
are superimposed on the two
peaks of z-axis coverage
distributions, while the best-fit
gamma curves are superimposed
on the dose distributions. The
CTDIvol and DLP distributions
for all the other protocols are
similar with the exceptions that
three Gaussian peaks were found
in z-axis coverage distributions
for CAP protocols and only one
peak for all the other protocols
(data not shown)
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them focused on smaller anatomical regions (e.g. liver alone).
In Fig. 2a we show the anatomical length distribution
for the abdomen protocols, which shows two Gaussian
peaks corresponding to abdomen (with a z-axis coverage
of 26±6 cm) and abdomen–pelvis (46±6 cm) regions.
Similar patterns were found for CAP acquisitions, but
with three peaks: abdomen (with a z-axis coverage of 26±
5 cm), abdomen–pelvis (44±5 cm) and complete CAP (64±
5 cm) acquisitions. For all the other protocols we found only
one peak.
Acquisitions for bolus synchronization
Although not required, some centres provided data (121 pa-
tients) for bolus synchronization acquisitions, performed when
contrast media are used. These are dynamic sequences, with a
very short z-axis coverage (0.5 or 1 cm), executed at low tube
currents, that synchronize the subsequent CT data acquisitions
to the required opacification by contrast enhancement.
Despite these acquisitions having a small impact on the total
DLP value (13 (10–18) mGy cm), the local dose delivered to
Table 3 Mean value (MV), standard deviation (SD) and 25th, 50th and 75th percentiles for CTDIvol (mGy), DLP (mGy cm) and total DLP (mGy cm)
for each CT protocol
CT protocol Exams n of CT acquisitions Anatomical region/ type of sequence Parameter MV SD 25th 50th 75th
Head 952 1,073 Whole head CTDIvol 64 17 56 60 69
DLP 1,086 336 867 1,041 1,312
Total DLP 1,223 493 892 1,133 1,382
157 170 Supratentorial CTDIvol 53 16 40 54 67
DLP 488 178 323 470 610
170 Posterior fossa CTDIvol 79 18 67 77 91
DLP 434 153 299 435 479
– Supratentorial + posterior fossa Total DLP 999 411 721 881 1,117
Chest 1,268 1,727 Chest CTDIvol 12 6 8 12 15
DLP 453 237 282 416 569
Total DLP 620 450 341 502 754
Abdomen 1,222 845 Abdomen CTDIvol 15 9 10 14 18
DLP 450 279 266 403 555
2,135 Abdomen–pelvis CTDIvol 15 6 10 14 18
DLP 733 320 487 677 920
2,980 All CTDIvol 15 7 10 14 18
DLP 653 334 406 580 843
Total DLP 1,595 1,010 799 1,399 2,157
CAP 1,237 733 Abdomen CTDIvol 14 8 9 13 17
DLP 414 244 259 371 508
1,210 Abdomen–pelvis CTDIvol 14 6 10 13 17
DLP 695 308 473 637 850
962 CAP CTDIvol 14 5 10 14 17
DLP 963 367 679 940 1,200
2,905 All CTDIvol 14 6 10 14 17
DLP 713 378 436 637 933
Total DLP 1,675 921 1,016 1,478 2,115
Cardiac 287 293 Angiographic CT CTDIvol 43 24 22 45 61
DLP 836 517 376 834 1,208
164 Calcium score CTDIvol 7 5 3 7 7
DLP 130 115 91 114 131
– All Total DLP 941 568 522 945 1,373
Spine 545 731 Spine CTDIvol 34 20 20 27 42
DLP 617 571 114 527 888
Total DLP 830 544 472 711 1,060
CTDIvol , DLP and total DLP of the head protocols are referenced to the 16-cm PPMAphantom; all the other values are referenced to the 32-cm phantom
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this short anatomical region (20 (13–26) mGy) was close to the
CTDIvol values for the main examination protocols (see
Table 3).
Dose predictors
From the multivariate analysis we found that the CTDIvol
was significantly associated with BMI, tube voltage, tube
rotation time, pitch and fixed tube current (allP <0.05) (Table 4).
CTDIvol increased with higher values of all parameters
(exp(b )>1) except for pitch (exp(b )=0.72). In particular, we
found a correlation between CTDIvol and BMI for chest,
abdomen and CAP protocols in Fig. 5. Compared with the
abdomen, the CTDIvol was significantly lower for chest
(exp(b )=0.84) and higher for head (exp(b )=2.18), but there
was no significant difference for the CAP (P=0.083) and
spine protocols (P=0.35).
Considering the cardiac protocol alone, contrast media,
voltage, CT technique, acquisition methods and reconstructed
slice thickness were significantly associated with CTDIvol (all
P <0.001). CTDIvol was higher for spiral acquisitions, for CT
acquisitions with contrast medium and for thin slices. We
further noted that 73.7 % of the CT angiograms were still
performed in the retrospective protocol with a CTDIvol of 53
(35–62) mGy and only 26.3 % were acquired in prospective
acquisition protocol though the latter involved a significantly
lower dose (10 (7–17) mGy).
Discussion
National and international surveys of CT practice are recom-
mended for estimating dose exposure to the population due to
CT examinations [1, 32] as well as for determining reference
values that can be used as benchmarks for dose optimisation.
The introduction of MDCT has brought with it the use of
more varied exposure conditions relative to previous CT
systems, not only through technological advances, but also
from a clinical transition, as CT examinations have become
less organ-targeted by providing more extensive coverage and
dynamic information.
CT optimisation now requires a good knowledge of both
CT technology and dose dependencies in order to tailor the
choice of acquisition parameters to the clinical indication and
patient size. The choice of parameters certainly differs between
the various CT systems and, for the same CT indication, may
also vary widely from hospital to hospital. These differences
are reflected in our work.
This study is the first nationwide Italian survey on MDCT,
and covers five common radiological CTexaminations as well
as cardiac CT. The International Commission on Radiological
Protection (ICRP) recommends that DRLs are set for “com-
mon diagnostic procedures” [32] because less commonly
performed examinations can be subject to confounding factors
in the statistical analysis, and do not represent everyday prac-
tice. As we do not have detailed data on the number of CT
examinations performed in Italy for each protocol, but only a
total number per year [27], we estimate that the six analysed
Fig. 3 Percentages of CT examinations divided according to the number
of CT acquisitions executed in the three most common body protocols.
Note that multiphase (n>1) CTexaminations dominate in case of abdomen
and CAP protocols
Fig. 4 Total DLP versus the number of phases per CT examination for
the most common body protocols. The height of the box displays the
interquartile range with the 25th and 75th percentiles represented by the
lower and upper edges of the box, respectively. The horizontal bold line
in the box corresponds to the median. The lower whisker is the 25th
percentile minus 1.5 times the interquartile range, the upper whisker is the
75th percentile plus 1.5 times the interquartile range. The bold horizontal
line corresponds to the median value per protocol
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protocols account for 75 % of all the examinations performed
according to the US IMV CT benchmark report [28].
Unlike previous studies and unlike the experience of the
UK dose survey, we gathered additional data in order to better
describe current practice. In particular, we included the now
widely diffuse CAP examinations [33] and, for each patient
examination, we analysed the data corresponding to each
phase of CT data acquisition, in order to correctly account
for multiphase studies [34].
We remark that we collected less data than expected (56 %)
for spine examinations, because many centres declared that
referrals for CTspine have diminished through replacement by
MR studies and/or included in CAP examinations in the case
of trauma. Further, the spine data were not homogeneous, with
a wide variation seen in z-axis coverage as some centres
perform CT on single vertebra, whereas others cover a larger
spine region. Cardiac studies, on the other hand, are growing in
number, but are still highly specific examinations performed in
a few dedicated centres; they were analysed in order to have a
picture of this emerging practice.We concentrated our study on
MDCT systems that can acquire 16 or more slices, because
they now represent the most widely diffused CT apparatus in
Italy [27] and according to a US market analysis [35] will
continue to account for a major share of the market over the
next 5–6 years. In future surveys, however, it will likely be
necessary to include other examinations, e.g. CT colonoscopy
or CT screening, as well as giving particular attention to 128-
slice or more MDCT systems as their use expands.
In Table 5 we compare the 75th percentiles of CTDIvol and
DLP of the present study to other European surveys, based on
data collection of patient CT examinations on MDCTsystems
[2, 16, 21]. European DRLs, established by the 2004 Europe-
an guidelines, and the very recent Dose Data Med 2 [36]
results, based on a DRL collection in several European coun-
tries, are also reported, whereas national DRL collections
were omitted [37]. We discuss the results in detail below.
Head
The 75th percentile of the CTDIvol (69 mGy) for the whole
head (Table 5) is in agreement with other surveys; however,
we record a higher DLP (1,312 mGy cm). This may be due to
the relatively frequent use of spiral acquisitions (47.4 %),
because they are affected by over-ranging effects that are,
now, included in the reported DLP. Those effects can account
roughly for a 20% increase in the DLP for those CTacquisition
lengths [38].
Also to be considered is that some centres still divide the
head study into two different parts, with higher radiation dose
due to a dedicated posterior fossa (91 mGy) CT data acquisi-
tion. However, as these are always axial acquisitions, the over-
ranging effects are not present and the DLP (1,117mGy cm) is
smaller than that obtained in whole-head CT.
Body (chest, abdomen, CAP)
As mentioned in the results, the clinical practice for body CT
examinations has become quite complex, because modern CT
technology allows fast acquisitions and many different CT
techniques. This has resulted in a wide variety in the CT
studies being performed, even for the same clinical indication
within the same centre.
In the dosimetric analysis reported in Table 3, Figs. 3 and 4,
we highlight some aspects of present clinical practice that
have acquired important roles in determining patient dose
since the introduction of MDCT. In particular, the number of
multiphase CT examinations (Fig. 3) has increased greatly for
the abdomen and CAP protocols; a single abdominal study
can consist of acquisitions of different anatomical coverage,
concentrated on the abdomen alone or covering both the
abdomen and pelvis region, whereas a CAP study can include,
not only the CAP acquisition, but also abdomen and abdo-
men–pelvis CT acquisitions. We therefore analysed the
CTDIvol and the DLP, important for dose optimisation, sepa-
rately from the total DLP, important for the evaluation of the
total dose absorbed by the patient and, in general, for the
estimation of population exposure risk. In addition, we sepa-
rated the contributions to exposure due to CT acquisitions of
Table 4 Association between CTDIvol and scanning modalities and
patient BMI: exponential coefficients and 95 % confidence intervals
(CIs) of the GEE analysis and relative P values
Variablesa Exp(b) 95 % CI P value
BMI (kg/m2)*b 1.14 (1.11; 1.16) <0.001
CT protocol vs abdomen protocol**
Spine 0.91 (0.73; 1.12) 0.350
Head 2.18 (1.89; 2.52) <0.001
Chest 0.84 (0.77; 0.92) <0.001
CAP 1.07 (0.99; 1.15) 0.083
Contrast media (yes vs no)** 1.01 (0.99; 1.04) 0.338
Tube voltage (kV)b* 1.11 (1.08; 1.15) <0.001
Tube current modulation (yes vs no)** 1.00 (0.94; 1.05) 0.941
Tube rotation time (s)b* 1.12 (1.01; 1.24) 0.035
Scan FOV (mm)b* 1.03 (0.96; 1.11) 0.355
Pitchb* 0.72 (0.69; 0.75) <0.001
Reconstructed slice thickness (mm)b* 0.95 (0.88; 1.03) 0.229
Fixed tube current (mA)b* 1.20 (1.16; 1.23) <0.001
aAcquisition mode, reconstruction filter, scanning technique, scan length
were omitted as they resulted non-statistically significant at univariate
analysis
b Standardized variables
*For a quantitative explanatory variable, exp(b) expresses the relative
variation in CTDIvol when it changes by 1 unit
**For a categorical explanatory variable, exp(b) expresses the relative
variation in CTDIvol of each category versus the reference
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Fig. 5 Interquartile range of CTDIvol (mGy) versus World Health Organisation BMI (kg/m
2) cut-off points for chest, abdomen and CAP protocols. The
horizontal line indicates the CTDIvol median by protocol; underweight, BMI<18.5; normal, 18.5<BMI<25; overweight, 25<BMI<30; obese, BMI>30
Table 5 75th percentiles of CTDIvol and DLP from the present survey and comparison with the 75th percentiles from previous large surveys and with
the European Guidelines recommendations and European Dose Datamed2 (DDM2) project
Anatomical regions Italy 2011 (this survey) UK 2003 [16] b Ireland 2010 [21] EUR 2004 [2] Dose Datamed2 2010 [36]c
CTDIvol DLP CTDIvol DLP CTDIvol DLP CTDIvol DLP CTDIvol DLP
Head a 69 1,312 931 66 940 60 990 50–75 (60) 760–1,300 (1,000)
Posterior fossa 91 479 103 – – – – – – –
Supratentorial 67 610 63 – – – – – – –
Chest 15 569 13 576 9 (11) 390 12 430 10–30 (10) 270–700 (400)
Abdomen 18 555 14 472 – – – – 13–35 (25) 400–740
Abdomen–pelvis 18 920 14 550 12 598 16 726 – 460–1,200 (800)
CAP 17 1,200 13 937 11 845 – – – –
Cardiac 61 1,208 – – – – – – – –
Spine 42 888 – – – – – – – –
a CTDIvol and DLP of the head are referenced to the 16-cm PPMA phantom; all the other values are referenced to the 32-cm phantom
b The values taken from the UK survey are those obtained for multislice CT scanners
c From DDM2 project we show the range of mean values collected in each country and the most frequent value (in parentheses)
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the abdomen, abdomen–pelvis and CAP anatomical regions:
whereas their CTDIvol values are similar and compatible with
the analysis performed including all those phases (14 (10–18)
and 14(10–17) mGy for abdomen and CAP respectively), their
DLP differ significantly. In abdomen studies, for example, we
found a 75th percentile DLP of 555mGy cm for the abdominal
CTacquisition and of 920 mGy cm for the combined abdomen
and pelvis, resulting in a 75th percentile DLP of 843 mGy cm
for the overall abdomen protocol distribution. This difference
becomes important in the context of choosing a reference level,
because the intermediate value of 843 mGy cm from the
overall analysis may be inappropriate for the optimisation of
either abdominal or abdomen–pelvis acquisitions.
In comparison with other surveys, our CTDIvol and DLP
75th percentiles were higher, suggesting the need for further
optimisation. The present Italian law (D. Lgs 187/2000) is still
based upon the DRL of the 1999 European guidelines, the
higher values of which could have lowered the attention level.
However, our data are within the DDM2 [36] range and in
agreement with recent DRL collections in Germany and
France [25, 26].
It is notable that, in the abdomen and CAP protocols, the
total DLP (Fig. 4 and Table 3) has reached very high values as
a direct consequence of the increased number of phases. As
shown in Fig. 4, the total DLP in four-phase examinations
reached median values (2,195 mGy cm) that are more than
three times higher than the single-phase acquisition DLP
(656 mGy cm) and are 50 % higher than the median values
found from the overall abdomen analysis (1,399 mGy cm).
Our multiphase data cannot be compared with other sur-
veys easily, as in most cases they did not explicitly deal with
this issue. A comparison can be made with the recent Irish
survey [21], where an analysis of multiphase abdominal stud-
ies was included. The 75th percentile for DLP (2,
156 mGy cm) in the present survey was almost twice the
value they reported (1,115 mGy cm). This can be explained
in part by our higher CTDIvol (18 mGy vs 13 mGy), although
a major factor could also be the higher number of phases
performed. However this possibility cannot be verified as they
state neither the number of phases nor the clinical indications.
In the chest protocol, multiphase examinations are present,
but account for only 31 % of all chest examinations, with
correspondingly small variation in anatomical coverage. The
75th percentiles we found for CTDIvol and DLP (15 mGy and
569 mGy cm respectively) are slightly above the values re-
ported in other surveys, but in good agreement with the
DDM2 results [36] (see Table 5).
Cardiac
Except for one centre, a 64-sliceMDCTsystemwas the choice
for cardiac applications.
Since over half of the centres performing cardiac CT (6 of
11) acquire the calcium scoring before the angiographic
acquisition, we analysed the data for both (Tables 2 and 3).We
found the angiographic phases to be slightly below the values
recorded in the international Hausleiter study [39] for CTDIvol
(45 (22–61) mGy vs 52.7 (37.1–72.8) mGy), and DLP (834
(376–1,208) mGy cm vs 885 (568–1,259) mGy cm). The
calcium score CT acquisitions have a much smaller impact
on patient dose, contributing just 7 (3–7) mGy to the CTDIvol
and 114 (91–131) mGy cm to the DLP.
Optimisation
The update of DRLs to new clinical practice is the starting
point for dose optimisation, as it allows centres to easily
compare their practice.
Our results suggest that the increased number of multiphase
examinations is the principal factor affecting the total dose de-
livered to the patient. Attention should be paid in order to reduce
the number of unnecessary acquisitions and to carefully select
patients undergoing multiphase studies. In this context, although
updated DRLs can still refer to single CT acquisitions (CTDIvol
and DLP) in order to attempt optimisation of single-phase CT
acquisitions, the monitoring of total DLP and number of phases
may help in controlling the consistent increase of patient expo-
sure due to multiphase examinations. Before the introduction of
MDCTs, the distinction between DLP and total DLP was less
important, because single-phase acquisitions dominated heavily.
Meanwhile, dose reduction should still be sought with a
careful selection of CT acquisition parameters, possibly cus-
tomized to clinical indication and patient characteristics. BMI,
indeed, is a known major determinant factor of image quality
for body examinations [39] and it is well known that image
noise increases with higher BMI when CT parameters, such as
tube current and voltage, are kept constant.
For those centres that collected patient height and weight,
we observed that CTDIvol increased with BMI, probably owing
to a proper tube current adaptation obtained with the automatic
modulation systems. A further improvement and dose reduc-
tion, however, are expected by also adapting tube voltage (kV)
to BMI, which until now has seldom been different from
120 kV. The only exception was represented by the cardiac
protocols. Furthermore, despite the extensive employment of
spiral CT acquisitions, high pitch values (>1) were rarely cho-
sen. Finally, in the cardiac protocol, the prospective mode
should be encouraged whenever possible even in angiographic
phases, because a dose reduction of 80 % could be reached.
Promising CT dose reduction technologies, like the iterative
reconstruction algorithms or tube voltage adapting systems, were
not considered in this analysis as they started appearing around
the time of data collection. Future large-scale surveys will be
needed to establish the effect of these emerging tech-
niques on clinical practice.
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Limitations
The recruitment for this survey may have been biased toward
radiology departments interested in dose optimisation. The
wide range of participating centres, however, appears repre-
sentative of the national situation [40]. In fact, we included
large academic hospitals and small district hospitals with a
diffuse regional distribution mainly from the National Health
Service that actually perform the large majority of the MDCT
examinations in Italy. An all-inclusive patient survey would
be more precise, but would also require a huge amount of time
and money and, probably, would become rapidly old before
its completion.
The registration of tube current modulation settings and
beam collimation is not standardized between different CT
manufacturers; consequently those parameters were not in-
cluded in the statistical analysis. Their effects on dose are
included in the CTDIvol and DLP. Finally, a dedicated analysis
would be useful in order to fully understand the implications
of new dose reduction algorithms.
Conclusion
In summary this nationwide audit of MDCT practice can act
as a starting point for updating Italian DRLs, and could be a
reference for European optimisation programmes.
Exposure levels were evaluated for the most common CT
protocols, including multiphase studies, where the highest
doses were registered. The high variability in CT protocols
and comparison with other surveys suggests that dose reduc-
tion could be achieved.
DRLs are a quality control measure to avoid bad practice;
therefore CTDIvol and DLP, though for single CTacquisitions,
are still necessary for obtaining optimisation. At the same
time, total DLP and the number of CT acquisitions of multi-
phase examinations could be useful to keep under control the
relevant dose increase due to these growing practices.
The use of the radiology information system (RIS), as well
as structured reports and automatic tools for dose monitoring,
may help in CT patient data collection, reducing operator
work and manual reporting errors. However it is important
to keep in mind that some patient data such as weight, height
or clinical indication are manually recorded before patient
examination and can therefore include mistakes. Furthermore,
the variety of procedures (that can include multiple acquisi-
tions on various anatomical regions or different indications)
still imposes the need for careful data collection and a detailed
analysis in order to compare homogeneous data.
Large-scale patient dose surveys still remain an important
approach to evaluating dose exposure in clinical practice and
should encourage radiologists and radiographers to optimise
their MDCT protocols.
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Appendix
Participating centres
AOUP Policlinico Palermo, Ospedale P. V. Fazzi Lecce,
Ospedale P.O. Spirito Santo Pescara, Ospedali Riuniti
Ancona, Ospedale Maggiore Trieste, Azienda Ospedaliero
Universitaria Careggi Firenze, A.O OIRM Sant'Anna Torino,
Ospedale Belcolle ASL Viterbo, IRCCS Policlinico San
Donato Milanese, Fatebenefratelli Sangiovanni Calabita
Roma, Istituto Oncologico Veneto IRCCS Padova, Istituto
Europeo di Oncologia Milano, Hsr Giglio Cefalù, Ospedale
AOU Maggiore della Carità Novara, Ospedale San Donato
Usl 8 Arezzo, Ospedale Carlo Poma Mantova, Istituto per la
ricerca e la cura del cancro di Candiolo, Fondazione IRCC
Policlinico San Matteo Pavia, Ospedale Circolo Fondazione
Macchi Varese, Ospedale Niguarda Milano, Istituto Tumori
Genova, ASL Cuneo 1, AO SS. Antonio e Biagio e C. Arrigo
Alessandria, PO Santa Maria delle Grazie Pozzuoli, Ospedale
San Bassiano Ulss3 Bassano del Grappa, Ospedale Santa
Maria delle Croci Ravenna, Istituti Ospitalieri Cremona,
A.O Città della salute e della scienza Torino, Ospedale
Regionale U. Parini Ausl Valle d'aosta, Asl2 Savonese
Ospedale Santa Corona Pietra Ligure, San Raffaele Milano,
Azienda Ospedaliero Universitaria di Modena Policlinico,
Azienda Ospedaliera San Gerardo Monza, Azienda
Ospedaliera Polo Universitario L. Sacco Milano, Azienda
Sanitaria di Firenze Ospedale del Mugello, Policlinico
Universitario Messina, Azienda Sanitaria Locale Torino
Ospedale Martini, Ospedale Asl 1 Imperiese Stabilimento
Ospedaliero Imperia, Sanremo e Bordighera, Azienda
Ospedaliera di Careggi Firenze, ASL 2 Savonese Ospedale
Santa Maria di Misericordia Albenga, Azienda Ospedaliera
Universitaria Santa Maria della Misericordia Udine, Ospedale
Schio Thiene, Fondazione IRCCS Cà Grande Ospedale
Maggiore Policlinico Milano, Ospedale Santa Chiara Trento,
Asl 3 Genovese Villa Scassi Genova, Istituti Fisioterapici
Ospedalieri Regina Elena Roma, Centro Cardiologico
Monzino Milano, Fondazione IRCCS Istituto nazionale
Tumori Milano, Ulss 20 Verona Ospedale Fracastoro,
Azienda Ospedaliera Santa Maria della Misericordia Perugia,
Asl Sassari Ospedale Santissima Annunnziata, Spedali
Civili di Brescia, Azienda Ospedaliera Provincia Lecco,
AOU Ospedale OORR San Giovanni di Dio e Ruggi
D'aragona Salerno, Azienda Ospedaliera di Catanzaro
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Pugliese-Ciaccio, ASL TO 1 Ospedale Evangelico Valdese,
Ospedale di Bressanone
Electronic appendix
For each CT examination performed, the phase 2 datasheet
included the main data of the patients enrolled in the survey
(age, gender, pseudonymous ID number and, if available, the
weight and height) and the clinical indication.
For the main technical parameters that can affect
dose, the datasheet included: tube voltage, use of automatic
(anatomy-based) tube current modulation, fixed tube current
value (for acquisitions without automatic modulation), the avail-
able current range (for automatic modulated acquisitions), tube
rotation time, reconstructed slice thickness, beam collimation,
CT field of view (CTacquisition FOV), z-axis length, the use of
axial or spiral CT technique, pitch (for spiral acquisitions),
reconstruction filter, the use of contrast agent and, if available,
the image quality index used and the average mAs. For cardiac
acquisitions, the presence of electrocardiographically controlled
tube current modulation (ECTCM), the administration of beta-
blockers, and the use of prospective vs retrospective acquisition
mode were also recorded.
Finally, the dosimetric parameters of each phase were
retrieved from the dose reports in terms of mean CTDIvol
and Dose Length Product (DLP). The total DLP, referring to
the complete patient examination, was also collected for
completeness.
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